ACS - Risk Stratification: Difference between revisions
No edit summary |
|||
| Line 1: | Line 1: | ||
== Likelihood That Signs/Symptoms represent ACS 2/2 CAD == | == Likelihood That Signs/Symptoms represent ACS 2/2 CAD == | ||
{| cellspacing="1" cellpadding="3" border="0" bgcolor="#666666" width="100%" | {| cellspacing="1" cellpadding="3" border="0" bgcolor="#666666" width="100%" | ||
|- | |- style="font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | ||
! bgcolor="#ffffff" align="left" valign="top" rowspan="1" | Feature | |||
! | ! bgcolor="#ffffff" align="left" valign="top" rowspan="1" | High Likelihood (any of the following) | ||
! | ! bgcolor="#ffffff" align="left" valign="top" rowspan="1" | Intermediate Likelihood (absence of high-likelihood features and presence of any of the following) | ||
! | ! bgcolor="#ffffff" align="left" valign="top" rowspan="1" | Low Likelihood (absence of high- or intermediate-likelihood features but may have) | ||
|- | |- style="font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | ||
| | | bgcolor="#ffffff" align="left" valign="top" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" rowspan="4" class="font12" | History | ||
| | | bgcolor="#ffffff" align="left" valign="top" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | Chest or left arm pain or discomfort as chief symptom reproducing prior documented angina | ||
| | | bgcolor="#ffffff" align="left" valign="top" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | Chest or left arm pain or discomfort as chief symptom | ||
| | | bgcolor="#ffffff" align="left" valign="top" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | Probable ischemic symptoms in absence of any of the intermediate-likelihood characteristics | ||
|- | |- style="font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | ||
| | | bgcolor="#ffffff" align="left" valign="top" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" rowspan="3" class="font12" | Known history of coronary artery disease, including myocardial infarction | ||
| | | bgcolor="#ffffff" align="left" valign="top" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | Age >70 y old | ||
| | | bgcolor="#ffffff" align="left" valign="top" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" rowspan="3" class="font12" | Recent cocaine use | ||
|- | |- style="font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | ||
| | | bgcolor="#ffffff" align="left" valign="top" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | Male sex | ||
|- | |- style="font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | ||
| | | bgcolor="#ffffff" align="left" valign="top" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | Diabetes mellitus | ||
|- | |- style="font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | ||
| | | bgcolor="#ffffff" align="left" valign="top" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | Examination | ||
| | | bgcolor="#ffffff" align="left" valign="top" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | Transient mitral regurgitation murmur, hypotension, diaphoresis, pulmonary edema, or rales | ||
| | | bgcolor="#ffffff" align="left" valign="top" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | Extracardiac vascular disease | ||
| | | bgcolor="#ffffff" align="left" valign="top" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | Chest discomfort reproduced by palpation | ||
|- | |- style="font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | ||
| | | bgcolor="#ffffff" align="left" valign="top" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" rowspan="3" class="font12" | ECG | ||
| bgcolor="#ffffff" align="left" valign="top" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" rowspan="3" class="font12" | New, or presumably new, transient ST-segment deviation (1 mm or greater) or T-wave inversion in multiple precordial leads | |||
| | | bgcolor="#ffffff" align="left" valign="top" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | Fixed Q waves | ||
| | | bgcolor="#ffffff" align="left" valign="top" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" rowspan="2" class="font12" | T-wave flattening or inversion <1 mm in leads with dominant R waves | ||
|- | |- style="font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | ||
| bgcolor="#ffffff" align="left" valign="top" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" rowspan="2" class="font12" | ST depression 0.5–1.0 mm or T-wave inversion >1 mm | |||
|- | |- style="font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | ||
| | | bgcolor="#ffffff" align="left" valign="top" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | Normal ECG | ||
|- | |- style="font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | ||
| | | bgcolor="#ffffff" align="left" valign="top" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | Cardiac markers | ||
| | | bgcolor="#ffffff" align="left" valign="top" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | Elevated cardiac troponin I, troponin T, or MB fraction of creatine kinase | ||
| | | bgcolor="#ffffff" align="left" valign="top" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | Normal | ||
| | | bgcolor="#ffffff" align="left" valign="top" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | Normal | ||
|} | |} | ||
== Short-Term Risk of Death or Nonfatal Myocardial Infarction by Risk Stratification in Patients with Unstable Angina == | == Short-Term Risk of Death or Nonfatal Myocardial Infarction by Risk Stratification in Patients with Unstable Angina == | ||
Revision as of 05:30, 17 July 2011
Likelihood That Signs/Symptoms represent ACS 2/2 CAD
| Feature | High Likelihood (any of the following) | Intermediate Likelihood (absence of high-likelihood features and presence of any of the following) | Low Likelihood (absence of high- or intermediate-likelihood features but may have) |
|---|---|---|---|
| History | Chest or left arm pain or discomfort as chief symptom reproducing prior documented angina | Chest or left arm pain or discomfort as chief symptom | Probable ischemic symptoms in absence of any of the intermediate-likelihood characteristics |
| Known history of coronary artery disease, including myocardial infarction | Age >70 y old | Recent cocaine use | |
| Male sex | |||
| Diabetes mellitus | |||
| Examination | Transient mitral regurgitation murmur, hypotension, diaphoresis, pulmonary edema, or rales | Extracardiac vascular disease | Chest discomfort reproduced by palpation |
| ECG | New, or presumably new, transient ST-segment deviation (1 mm or greater) or T-wave inversion in multiple precordial leads | Fixed Q waves | T-wave flattening or inversion <1 mm in leads with dominant R waves |
| ST depression 0.5–1.0 mm or T-wave inversion >1 mm | |||
| Normal ECG | |||
| Cardiac markers | Elevated cardiac troponin I, troponin T, or MB fraction of creatine kinase | Normal | Normal |
Short-Term Risk of Death or Nonfatal Myocardial Infarction by Risk Stratification in Patients with Unstable Angina
| Feature | High Likelihood (at least one of the following features must be present) | Intermediate Likelihood (no high-risk feature, but must have one of the following) | Low Likelihood (no high- or intermediate-risk feature, but may have any of the following) |
|---|---|---|---|
| History | Accelerating tempo of ischemic symptoms in preceding 48 h | Prior myocardial infarction, peripheral or cerebrovascular disease, or coronary artery bypass grafting; prior aspirin use | — |
| Character of the pain | Prolonged ongoing (>20 min) rest pain | Prolonged (>20 min) rest angina, now resolved, with moderate or high likelihood of CAD | Increased angina frequency, severity, or duration |
| Rest angina (>20 min) or relieved with rest or sublingual nitroglycerin | Angina provoked at a lower threshold | ||
| New-onset angina with onset 2 wk to 2 mo before presentation | |||
| Nocturnal angina | |||
| New-onset or progressive Canadian Cardiology Society Class III or IV angina (Table 53-0.1) in the past 2 wk without prolonged (>20 min) rest pain but with intermediate or high likelihood of CAD (Table 53-2) | |||
| Clinical findings | Pulmonary edema, most likely due to ischemia | Age >70 y old | Chest discomfort reproduced by palpation |
| New or worsening mitral regurgitation murmur | |||
| S3 or new/worsening rales | |||
| Hypotension, bradycardia, tachycardia | |||
| Age >75 y old | |||
| ECG | Angina at rest with transient ST-segment changes >0.5 mm | T-wave changes, pathologic Q waves, or resting ST depression <1 mm in multiple lead groups (anterior, inferior, lateral) | Normal or unchanged ECG |
| Bundle-branch block, new or presumed new | |||
| Sustained ventricular tachycardia | |||
| Cardiac markers | Elevated cardiac TnT, TnI, or CK-MB (e.g., TnT or TnI >0.1 nanogram/mL) | Slightly elevated cardiac TnT, TnI, or CK-MB (e.g., TnT >0.01 but <0.1 nanogram/mL) | Normal |
See Also
Acute Coronary Syndrome (Main)
Source
2007 ACC/AHA Guidelines for the Management of Patients with UA/NSTEMI
